Literature DB >> 12734404

Viral mimicry of the complement system.

John Bernet1, Jayati Mullick, Akhilesh K Singh, Arvind Sahu.   

Abstract

The complement system is a potent innate immune mechanism consisting of cascades of proteins which are designed to fight against and annul intrusion of all the foreign pathogens. Although viruses are smaller in size and have relatively simple structure, they are not immune to complement attack. Thus, activation of the complement system can lead to neutralization of cell-free viruses, phagocytosis of C3b-coated viral particles, lysis of virus-infected cells, and generation of inflammatory and specific immune responses. However, to combat host responses and succeed as pathogens, viruses not only have developed/adopted mechanisms to control complement, but also have turned these interactions to their own advantage. Important examples include poxviruses, herpesviruses, retroviruses, paramyxoviruses and picornaviruses. In this review, we provide information on the various complement evasion strategies that viruses have developed to thwart the complement attack of the host. A special emphasis is given on the interactions between the viral proteins that are involved in molecular mimicry and the complement system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734404      PMCID: PMC7090525          DOI: 10.1007/bf02970145

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  130 in total

1.  Opsonic complement component C3 in the solitary ascidian, Halocynthia roretzi.

Authors:  M Nonaka; K Azumi; X Ji; C Namikawa-Yamada; M Sasaki; H Saiga; A W Dodds; H Sekine; M K Homma; M Matsushita; Y Endo; T Fujita
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

2.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  An ancient lectin-dependent complement system in an ascidian: novel lectin isolated from the plasma of the solitary ascidian, Halocynthia roretzi.

Authors:  H Sekine; A Kenjo; K Azumi; G Ohi; M Takahashi; R Kasukawa; N Ichikawa; M Nakata; T Mizuochi; M Matsushita; Y Endo; T Fujita
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

4.  Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells.

Authors:  Y Hidaka; Y Sakai; Y Toh; R Mori
Journal:  J Gen Virol       Date:  1991-04       Impact factor: 3.891

5.  C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.

Authors:  T Kinoshita; Y Takata; H Kozono; J Takeda; K S Hong; K Inoue
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

6.  Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.

Authors:  W E Robinson; D C Montefiori; W M Mitchell
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

7.  Tyrosine is a potential site for covalent attachment of activated complement component C3.

Authors:  A Sahu; M K Pangburn
Journal:  Mol Immunol       Date:  1995-07       Impact factor: 4.407

8.  Sialylated oligosaccharides O-glycosidically linked to glycoprotein C from herpes simplex virus type 1.

Authors:  F Dall'Olio; N Malagolini; V Speziali; G Campadelli-Fiume; F Serafini-Cessi
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

9.  Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus.

Authors:  M Manchester; M K Liszewski; J P Atkinson; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

10.  Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C.

Authors:  R J Frink; R Eisenberg; G Cohen; E K Wagner
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

View more
  46 in total

1.  Reciprocal antibody and complement responses of two chicken breeds to vaccine strains of Newcastle disease virus, infectious bursal disease virus and infectious bronchitis virus.

Authors:  R Baelmans; H K Parmentier; P Dorny; F Demey; D Berkvens
Journal:  Vet Res Commun       Date:  2006-07       Impact factor: 2.459

2.  Hepatitis B virus inhibits the expression of complement C3 and C4, in vitro and in vivo.

Authors:  Chengliang Zhu; Hui Song; Fengxia Xu; Wei Yi; Fang Liu; Xinghui Liu
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

3.  Identification of complement regulatory domains in vaccinia virus complement control protein.

Authors:  Jayati Mullick; John Bernet; Yogesh Panse; Sharanabasava Hallihosur; Akhilesh K Singh; Arvind Sahu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics.

Authors:  Li Zhang; Dimitrios Morikis
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

Review 5.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

6.  Structural principles within the human-virus protein-protein interaction network.

Authors:  Eric A Franzosa; Yu Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-16       Impact factor: 11.205

7.  Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus.

Authors:  Tony Schountz; Joseph Prescott; Ann C Cogswell; Lauren Oko; Katy Mirowsky-Garcia; Alejandra P Galvez; Brian Hjelle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

8.  Killing of Gram-negative bacteria with normal human serum and normal bovine serum: use of lysozyme and complement proteins in the death of Salmonella strains O48.

Authors:  G Bugla-Płoskońska; A Kiersnowski; B Futoma-Kołoch; W Doroszkiewicz
Journal:  Microb Ecol       Date:  2009-03-18       Impact factor: 4.552

9.  A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS.

Authors:  Weiguo Hu; Qigui Yu; Ningjie Hu; Daniel Byrd; Tohti Amet; Cecilia Shikuma; Bruce Shiramizu; Jose A Halperin; Xuebin Qin
Journal:  J Immunol       Date:  2009-12-02       Impact factor: 5.422

10.  Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions.

Authors:  Nathan P Manes; Ryan D Estep; Heather M Mottaz; Ronald J Moore; Therese R W Clauss; Matthew E Monroe; Xiuxia Du; Joshua N Adkins; Scott W Wong; Richard D Smith
Journal:  J Proteome Res       Date:  2008-01-19       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.